Q1 FY27 snapshot
Announcement Date21-Jul-26
Revenue (Top Line)₹443 Cr
Net Profit (Bottom Line)₹120 Cr
Earnings Per Share (EPS)₹2.13
Expenses₹323 Cr
Net profit margin (calculated)27.1%
Anthem Biosciences Ltd. (ANTHEM) Quarterly Results: Q1 FY27
Quick answer: Anthem Biosciences Ltd. (NSE: ANTHEM) reported Q1 FY27 revenue of ₹443 Cr and net profit of ₹120 Cr, with earnings per share (EPS) of ₹2.13, announced on 21-Jul-26.
That works out to a net profit margin of about 27.1% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Anthem Biosciences Ltd.'s Q1 FY27 results
Revenue of ₹443 Cr is what Anthem Biosciences Ltd. earned before costs. Net profit of ₹120 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 27.1%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Anthem Biosciences Ltd. results FAQs
What were Anthem Biosciences Ltd.'s Q1 FY27 results?
Anthem Biosciences Ltd. (NSE: ANTHEM) reported Q1 FY27 revenue of ₹443 Cr and net profit of ₹120 Cr, with earnings per share (EPS) of ₹2.13, announced on 21-Jul-26.
What is Anthem Biosciences Ltd.'s EPS for Q1 FY27?
Anthem Biosciences Ltd.'s earnings per share for Q1 FY27 was ₹2.13. EPS is net profit divided by the number of outstanding shares.
When did Anthem Biosciences Ltd. announce its Q1 FY27 results?
Anthem Biosciences Ltd. announced its Q1 FY27 results on 21-Jul-26.
What is Anthem Biosciences Ltd.'s net profit margin?
On the reported figures, Anthem Biosciences Ltd.'s Q1 FY27 net profit margin is about 27.1% (net profit ÷ revenue).